Cholesterol screening and management in children and young adults should start early--NO!

Clin Cardiol. 2012 Nov;35(11):665-8. doi: 10.1002/clc.22075.

Abstract

In 2011, an expert panel from the National Heart, Lung, and Blood Institute released recommendations for universal lipid screening and treatment of high cholesterol in children. There is no evidence that universal screening will help children lead longer, healthier lives. These recommendations will, however, fuel the epidemic of overtreatment that is currently threatening our healthcare system and our patients.

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Age Factors
  • Anticholesteremic Agents / adverse effects
  • Biomarkers / blood
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control*
  • Child
  • Cholesterol / blood*
  • Early Diagnosis
  • Evidence-Based Medicine
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / diagnosis*
  • Hypercholesterolemia / epidemiology
  • Hypercholesterolemia / therapy*
  • Mass Screening* / methods
  • Mass Screening* / standards
  • Practice Guidelines as Topic
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Risk Reduction Behavior
  • Young Adult

Substances

  • Anticholesteremic Agents
  • Biomarkers
  • Cholesterol